Butriptyline

This classification denotes an antidepressant agent with the molecular formula C21H27N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z22441975X, chemically known as 10,11-dihydro-n,n,beta-trimethyl-5h-dibenzo(a,d)cycloheptene-5-propylamine but generally known as butriptyline, which bears US NIH Compound Identifier 21772. Butriptyline most often comes in base, butriptylene, and hydrochloride forms. European Medicines Agency schedules Butriptyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13137MIG. The term BUTRIPTYLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules butriptyline in its Anatomical Therapeutic Chemical (ATC) Classification. BUTRIPTYLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butriptyline under HS 29214980 and SITC 51454. As of Q4 2014, BUTRIPTYLINE remains the US FDA Preferred Term for this commodity. Butriptyline bears US NLM identifiers UMLS ID C0054270 and NCI Concept Code C79855. SMILES: N(CC(CC1c2c(CCc3c1cccc3)cccc2)C)(C)C.